To further explore the potential of POLD4 in glioma, we conducted further analysis on the expression levels of POLD4 in glioma patients with different clinical characteristics using the CGGA_mRNAseq_325, CGGA_mRNAseq_693, CGGA_array_301, and Rembrandt datasets. This evidence concerns the gene POLD4 and central nervous system cancer.